News & Updates

Dose-escalated oral antidiabetic drug therapy may be less potent than reported

09 Feb 2022 by

In the real-world treatment of Asian patients with type 2 diabetes mellitus (T2DM), the blood glucose-lowering benefit following oral antidiabetic drug (OAD) dose escalation is lesser than what has been reported in clinical trials, according to a study from Singapore.

Dose-escalated oral antidiabetic drug therapy may be less potent than reported

09 Feb 2022

Waist-height ratio predicts severe diabetic eye disease risk in T1D

08 Feb 2022 by

Waist-height ratio (WHtR), a hallmark of central obesity, appears to be a good indicator for the risk of developing severe diabetic eye disease (SDED) in adults with type 1 diabetes (T1D), results of a 15-year cohort study suggest.

Waist-height ratio predicts severe diabetic eye disease risk in T1D

08 Feb 2022

Apatinib a new treatment alternative for thyroid cancer?

08 Feb 2022 by

In individuals with progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC), the VEGFR-2* inhibitor apatinib demonstrated significant clinical benefits in terms of progression-free survival (PFS) and overall survival (OS), with a manageable safety profile, findings from the phase III REALITY trial suggest.

Apatinib a new treatment alternative for thyroid cancer?

08 Feb 2022

CGM with low-carb nutrition counselling boosts glycaemic control in T2DM

08 Feb 2022 by

The combination of continuous glucose monitoring (CGM) and low-carbohydrate nutrition counselling can help improve glycaemic control in patients with type 2 diabetes mellitus (T2DM), according to a recent study.

CGM with low-carb nutrition counselling boosts glycaemic control in T2DM

08 Feb 2022

Regular follow-ups key to reducing eclampsia rates, maternal mortality

08 Feb 2022 by

Regular monitoring of expecting mothers can help reduce maternal death rates from eclampsia in the country, say experts.

Regular follow-ups key to reducing eclampsia rates, maternal mortality

08 Feb 2022

Next-gen sequencing paves way to discovery of novel forms of monogenic diabetes

07 Feb 2022 by

Targeted next-generation sequencing (NGS) appears to be useful for pinpointing causal variants in patients with suspected monogenic diabetes (MD), broadening the spectrum of new pathogenic variants and updating knowledge of the clinical features of patients with various forms of MD, according to a recent study.

Next-gen sequencing paves way to discovery of novel forms of monogenic diabetes

07 Feb 2022

Systemic inflammation mediates obesity-related severe COVID-19

04 Feb 2022 by

Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.

Systemic inflammation mediates obesity-related severe COVID-19

04 Feb 2022

Elevated vitamin B12 levels confer insomnia risk in diabetic patients

03 Feb 2022

Vitamin B12 concentrations in type 2 diabetes mellitus (T2DM) patients are linked to the incidence of insomnia and help pinpoint those who are likely to develop the condition according to a study.

Elevated vitamin B12 levels confer insomnia risk in diabetic patients

03 Feb 2022

Tirzepatide regulates metabolites, lipids in T2D

02 Feb 2022

Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.

Tirzepatide regulates metabolites, lipids in T2D

02 Feb 2022

Effect of interventions on anthropometric outcomes in PCOS varies by drug

02 Feb 2022

In the management of women with polycystic ovary syndrome (PCOS), metformin at various therapeutic doses appears to reduce body weight, body mass index, and waist circumference when compared with placebo, sitagliptin, and acarbose, according to the results of a meta-analysis. On the other hand, pioglitazone and rosiglitazone contribute to an increase in all three outcomes.

Effect of interventions on anthropometric outcomes in PCOS varies by drug

02 Feb 2022

News & Updates

Filter by Specialty:

Specialty:

Dose-escalated oral antidiabetic drug therapy may be less potent than reported

Dose-escalated oral antidiabetic drug therapy may be less potent than reported

Waist-height ratio predicts severe diabetic eye disease risk in T1D

Waist-height ratio predicts severe diabetic eye disease risk in T1D

Apatinib a new treatment alternative for thyroid cancer?

Apatinib a new treatment alternative for thyroid cancer?

CGM with low-carb nutrition counselling boosts glycaemic control in T2DM

CGM with low-carb nutrition counselling boosts glycaemic control in T2DM

Regular follow-ups key to reducing eclampsia rates, maternal mortality

Regular follow-ups key to reducing eclampsia rates, maternal mortality

Next-gen sequencing paves way to discovery of novel forms of monogenic diabetes

Next-gen sequencing paves way to discovery of novel forms of monogenic diabetes

Systemic inflammation mediates obesity-related severe COVID-19

Systemic inflammation mediates obesity-related severe COVID-19

Elevated vitamin B12 levels confer insomnia risk in diabetic patients

Elevated vitamin B12 levels confer insomnia risk in diabetic patients

Tirzepatide regulates metabolites, lipids in T2D

Tirzepatide regulates metabolites, lipids in T2D

Effect of interventions on anthropometric outcomes in PCOS varies by drug

Effect of interventions on anthropometric outcomes in PCOS varies by drug